Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Healius Provides 1H 2020 Results

26 Feb 2020  |  08:49:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: HLS 1H 2020 results, update on strategic initiatives

Healius provided 1H 2020 results. It announced underlying EBIT of $75.7m and underlying NPAT of $42.1m, increases of 4% and 8%, respectively, for the half-year ended 31 December 2019 (HY 2020). Reported EBIT was $45.0m and reported NPAT was $66.3m. Group revenue grew by 7% to just under $1bn supported by growth in Pathology and Montserrat. In 1H 2020, Imaging revenue grew by 5% to $202m following successful contract wins. The division's EBIT increased by 16% to $21m, with margin expansion underpinned by savings in consumables and property expenses from the Sustainable Improvement Program.

Please click here for full details

See more ASX300 News Announcements